ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.70
      0.13%
      US Tech 100
      17,617.63
      0.04%
      Dow Jones
      38,884.26
      0.08%
      Brent Oil
      82.705
      -0.19%
      Bitcoin
      62,751.37
      0.67%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Corautus Genetics (MM) (VEGF)

      7. Corautus Genetics (MM) (VEGF) News

      VEGF

      Corautus Genetics (VEGF)

      Corautus Genetics (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VEGF
      DateTimeSourceHeadlineSymbolCompany
      12:51PMiHub NewswireFeaturedCannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa
      06/04/20077:04PMPR Newswire (US)Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related ProposalsNASDAQ:VEGFCorautus Genetics (MM)
      05/29/20074:00PMPR Newswire (US)Corautus Genetics Receives Nasdaq Additional Deficiency NoticeNASDAQ:VEGFCorautus Genetics (MM)
      02/08/20078:00AMPR Newswire (US)Corautus Genetics and VIA Pharmaceuticals Announce Merger AgreementNASDAQ:VEGFCorautus Genetics (MM)
      01/17/200712:30PMPR Newswire (US)Corautus Announces DiscussionsNASDAQ:VEGFCorautus Genetics (MM)
      12/14/20064:00PMPR Newswire (US)Corautus Genetics Inc. Receives Determination Letter from Nasdaq Regarding Continued ListingNASDAQ:VEGFCorautus Genetics (MM)
      11/14/20068:00AMPR Newswire (US)Corautus Genetics Reports Third Quarter Financial ResultsNASDAQ:VEGFCorautus Genetics (MM)
      11/07/20063:00PMPR Newswire (US)Corautus Genetics Inc. to Host Conference Call on November 14, 2006NASDAQ:VEGFCorautus Genetics (MM)
      11/03/20064:10PMPR Newswire (US)Corautus Genetics Announces Redirection of Focus and Transition Of OfficersNASDAQ:VEGFCorautus Genetics (MM)
      10/10/20069:00AMPR Newswire (US)Corautus Genetics Announces Final Efficacy Results of GENASIS Phase IIb Clinical TrialNASDAQ:VEGFCorautus Genetics (MM)
      08/10/20068:58AMPR Newswire (US)Corautus Genetics Reports Second Quarter Financial ResultsNASDAQ:VEGFCorautus Genetics (MM)
      08/08/20069:00AMPR Newswire (US)Corautus Genetics Inc. to Host Conference Call on August 10, 2006NASDAQ:VEGFCorautus Genetics (MM)
      07/13/20068:58AMPR Newswire (US)Corautus Genetics Announces Partial Lifting of FDA Clinical Hold and Update on GENASIS Database LockNASDAQ:VEGFCorautus Genetics (MM)
      07/06/20069:00AMPR Newswire (US)Corautus Genetics Announces Conversion of Boston Scientific Debt Into EquityNASDAQ:VEGFCorautus Genetics (MM)
      06/20/20069:15AMPR Newswire (US)Corautus Genetics to Present at Jefferies Life Sciences ConferenceNASDAQ:VEGFCorautus Genetics (MM)
      05/31/20068:58AMPR Newswire (US)Corautus Genetics Announces Filing of Response to FDA Clinical HoldNASDAQ:VEGFCorautus Genetics (MM)
      05/26/20061:00PMPR Newswire (US)Corautus Genetics Receives NASDAQ Deficiency Notice Related to Minimum Bid PriceNASDAQ:VEGFCorautus Genetics (MM)
      05/15/20069:00AMPR Newswire (US)Corautus Genetics Reports an Update of its Therapeutic Development Program and First Quarter Financial ResultsNASDAQ:VEGFCorautus Genetics (MM)
      05/08/20069:00AMPR Newswire (US)Corautus Genetics Inc. to Host Conference Call on May 15, 2006NASDAQ:VEGFCorautus Genetics (MM)
      04/19/20069:00AMPR Newswire (US)Corautus Genetics Inc. Names Todd Stallings as Vice President - Clinical OperationsNASDAQ:VEGFCorautus Genetics (MM)
      04/10/20068:45AMPR Newswire (US)Corautus Announces Termination of Patient Enrollment in GENASIS Severe Angina Clinical TrialNASDAQ:VEGFCorautus Genetics (MM)
      04/04/200610:00AMPR Newswire (US)Corautus Genetics Inc. to Present at BIO 2006 Business ForumNASDAQ:VEGFCorautus Genetics (MM)
      03/20/20068:00AMPR Newswire (US)Corautus Genetics Reports Fourth Quarter and 2005 Financial Results and Provides Update on Temporary Suspension of GENASIS TriaNASDAQ:VEGFCorautus Genetics (MM)
      03/14/20068:31AMPR Newswire (US)Corautus Genetics Inc. Announces Developments in Clinical Trial and Public OfferingNASDAQ:VEGFCorautus Genetics (MM)
      03/10/20068:06AMPR Newswire (US)Corautus Genetics Inc. Announces Pricing of Equity OfferingNASDAQ:VEGFCorautus Genetics (MM)
      02/24/20064:42PMPR Newswire (US)Corautus Genetics Announces Proposed Public Offering of Common StockNASDAQ:VEGFCorautus Genetics (MM)
      02/23/20068:00AMPR Newswire (US)Corautus Genetics Announces Update on GENASIS TrialNASDAQ:VEGFCorautus Genetics (MM)
      01/26/20068:00AMPR Newswire (US)Corautus Genetics' Phase IIb Clinical Trial for Severe Angina Treatment Receives Go-Ahead from Data Safety Monitoring CommitteeNASDAQ:VEGFCorautus Genetics (MM)
      01/11/20068:00AMPR Newswire (US)Corautus Genetics Announces Collaboration for Phase I Trial for the Treatment of Critical Limb Ischemia with VEGF-2NASDAQ:VEGFCorautus Genetics (MM)
      11/10/20058:00AMPR Newswire (US)Corautus Genetics Reports Third Quarter ResultsNASDAQ:VEGFCorautus Genetics (MM)
       Showing the most relevant articles for your search:NASDAQ:VEGF